(Q27913808)

6

object named as

Owen A O'Connor

0 references

author name string

Laura K Fogli

1

0 references

Michael E Williams

2

0 references

Yvonne Reid

4

0 references

Kathleen Brown

describes a project that uses

5

0 references

publication date

July 2015

0 references

published in

Leukemia & Lymphoma

0 references

volume

56

0 references

issue

7

0 references

page(s)

2114-22

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.970548

Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.970548

Establishment and characterization of a new mantle cell lymphoma cell line M-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.970548

Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.970548

The emerging role of bortezomib in the treatment of indolent non-Hodgkin's and mantle cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.970548

Marked clinical activity of the proteasome inhibitor bortezomib in patients with follicular and mantle-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.970548

Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.970548

Bortezomib for the treatment of mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.970548

Induction of apoptosis in Jeko-1 mantle cell lymphoma cell line by resveratrol: a proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.970548

Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.970548

Defects of FA/BRCA pathway in lymphoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.970548

The seed stock concept and quality control for cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.970548

Establishment and characterization of a new mantle cell lymphoma cell line, Mino

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.970548

Z-138: a new mature B-cell acute lymphoblastic leukemia cell line from a patient with transformed chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.970548

Two new cell lines from B-prolymphocytic leukaemia: characterization by morphology, immunological markers, karyotype and Ig gene rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.970548

Expanded range of 11q13 breakpoints with differing patterns of cyclin D1 expression in B-cell malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.970548

Establishment and characterization of a mantle cell lymphoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.970548

Malignant hematopoietic cell lines: in vitro models for the study of mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.970548

The establishment of Epstein-Barr virus nuclear antigen-positive (SP-50B) and Epstein-Barr virus nuclear antigen-negative (SP-53) cell lines with t(11;14)(q13;q32) chromosome abnormality from an intermediate lymphocytic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.970548

Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.970548

Blastoid mantle cell lymphoma: evidence for nonrandom cytogenetic abnormalities additional to t(11;14) and generation of a mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.970548

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.970548